Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **heme detoxification pathway in Plasmodium** refers to a critical biochemical mechanism by which malaria parasites neutralize the toxic effects of free heme released during hemoglobin digestion inside infected red blood cells. As Plasmodium species degrade large amounts of host hemoglobin for nutrition, they release substantial quantities of free heme, which is highly cytotoxic due to its ability to generate reactive oxygen species. To survive, the parasite converts this free heme into an insoluble crystalline form called **hemozoin** ("malaria pigment") through a unique polymerization process not found in humans[1][3]. This conversion is facilitated by specific proteins such as the **Heme Detoxification Protein** (HDP), which has been identified as essential and conserved across Plasmodium species[1]. The inability to disrupt HDP genetically underscores its importance. This parasite-specific mechanism represents a major vulnerability exploited by several frontline antimalarial drugs—including chloroquine and artemisinin derivatives—which act by inhibiting or disrupting the crystallization/polymerization step. Failure to convert toxic free heme into inert crystals leads rapidly to parasite death[1][2]. Because humans do not possess an analogous intracellular crystallization system for handling excess intracellular hemoglobin-derived iron/heme, this target offers high selectivity. The centrality and uniqueness of this metabolic route make it one of malaria’s most important drug targets; however, incomplete understanding at the molecular level has limited development beyond existing therapies. Resistance mechanisms—such as altered trafficking or reduced activation—pose ongoing challenges but do not diminish its status as a validated therapeutic target[2].
Inhibition of hemozoin formation, leading to accumulation of toxic free heme within the parasite
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme detoxification pathway in Plasmodium.